Icon Advisers Inc Biomarin Pharmaceutical Inc Transaction History
Icon Advisers Inc
- $422 Million
- Q2 2025
A detailed history of Icon Advisers Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Icon Advisers Inc holds 17,706 shares of BMRN stock, worth $929,033. This represents 0.23% of its overall portfolio holdings.
Number of Shares
17,706
Previous 24,706
28.33%
Holding current value
$929,033
Previous $1.75 Million
44.27%
% of portfolio
0.23%
Previous 0.42%
Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
679Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.19 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$997 Million0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$828 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$793 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$645 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $9.75B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...